US Dermatologic Drug Approvals Rose Between 2012 and 2022 US Dermatologic Drug Approvals Rose Between 2012 and 2022

Of the 52 new drugs approved in the past decade, 21% were categorized as first in class, but more innovations are needed for skin diseases with unmet therapeutic needs, the authors said.Medscape Medical News
Source: Medscape Allergy Headlines - Category: Allergy & Immunology Tags: Dermatology Source Type: news